These results suggest that when cardiac Pde1C mRNA and PDE1C protein levels increased in the heart upon Wy-14,643 treatment, they were accompanied by reduced cAMP levels and increased levels of cTNI, indicating a possible onset of cardiac failure. Here, TNNI3 is linked to heart failure.